Stay Informed

Pfizer News

August 23, 2010
Topline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC)

August 23, 2010
World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children

August 9, 2010
Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A

August 3, 2010
Pfizer Reports Second-Quarter 2010 Results

July 29, 2010
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

July 23, 2010
EISAI INC. AND PFIZER INC ANNOUNCE U.S. FDA APPROVAL FOR NEW HIGHER-DOSE ARICEPT® (DONEPEZIL HCL) 23 MG TABLET FOR THE TREATMENT OF MODERATE-TO-SEVERE ALZHEIMER’S DISEASE

July 22, 2010
Pfizer to Offer Free Public Access to Mental Health Assessment Tools to Improve Diagnosis and Patient Care

July 19, 2010
Pfizer Suspends Chronic Pain Studies in Tanezumab Clinical Trial Program; Some Studies Continue in Areas of Unmet Medical Need

July 14, 2010
Pfizer and SMC Collaborate on Liver Cancer

July 13, 2010
New Research Presented at Alzheimer's Association International Conference on Alzheimer's Disease Indicates Alzheimer's Disease May Lead to Increased Comorbid Conditions and Economic Burdenhttp://pfizer.mediaroom.com/index.php?s=5149&item=5782

July 8, 2010
Pfizer to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at Alzheimer's Association International Conference on Alzheimer's Disease

July 7, 2010
Pfizer Strengthens Manufacturing Capabilities in Asia With Expansion of Singapore Nutrition Plant

June 29, 2010
Pfizer Invites Public to View and Listen to Webcast of August 3 Conference Call With Analysts

June 24, 2010
Pfizer Declares An 18-Cent Third-Quarter 2010 Dividend

June 23, 2010
Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program

June 21, 2010
Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg®

June 21, 2010
Caduet Reduces 10-Year Calculated Risk Of Coronary Heart Disease, Fatal Cardiovascular Disease

June 17, 2010
New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet, Contributes to Knowledge of NSAID-Associated Gastrointestinal Adverse Events

June 14, 2010
Pfizer Announces Creation Of Rare Disease Research Unit

June 2, 2010
Pfizer And Epocrates Partner To Give Healthcare Providers Access To Medical Information Specialists For Medication Questions

May 27, 2010
Pfizer Announces EMPHASIS-HF Trial To Halt Recruitment Due To Significant Benefit Observed In Patients Treated With Inspra® (Eplerenone)

May 26, 2010
Pfizer Appoints Mikael Dolsten President Of Worldwide Research And Development

May 25, 2010
Pfizer Animal Health Expands Global Commitment To A Safe Food Supply With A New Focus On Healthy Fish

May 20, 2010
Pfizer Oncology To Present New Clinical Data From Ten Molecules Across Multiple Tumor Types

May 19, 2010
Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

May 18, 2010
Pfizer Global Manufacturing Announces Plans To Reconfigure Its Global Plant Network

May 17, 2010
Pfizer, Washington University Announce Groundbreaking Collaboration

May 12, 2010
Pfizer Enters Into Agreement With Ergonex Pharma To Acquire Investigational Treatment For Pulmonary Arterial Hypertension

May 5, 2010
Pfizer Animal Health Announces First Recipients of New $2 Million Veterinary Scholarship Program

May 4, 2010
Pfizer Reports First-Quarter 2010 Results; Reaffirms 2010 Financial Guidance

April 23, 2010
World Bank And Pfizer Announce Initiative To Help Improve Healthcare Delivery In Developing Countries

April 23, 2010
Pfizer And Medicines For Malaria Venture Seek To Expand Fight Against Malaria With Intermittent Preventive Treatment Option For Pregnant Women

April 22, 2010
Pfizer Discontinues Phase 3 Trial of Sutent® in Advanced Hepatocellular Carcinoma

April 22, 2010
Pfizer Hosts Annual Meeting Of Shareholders; Declares 18-Cent Second-Quarter 2010 Dividend

April 15, 2010
Stemgent and Pfizer Announce Collaboration

Click here for more Pfizer news.

Pfizer Launches Orphan and Genetic Diseases Unit (June 2010)

We Came. We Listened. We Heard. (Pfizer Plus July 2010 - registered users only)

Looking Back on 2009, Ahead to 2010 (Pfizer Plus 4Q 2009 - registered users only)

Pfizer and Wyeth Are One (Pfizer Plus 4Q 2009 - registered users only)

Pfizer Delivers a Solid Performance (Pfizer Plus 4Q 2009 - registered users only)

Pfizer Expands Its Mission, Establishes New Core Commitments (Pfizer Plus 4Q 2009 - registered users only)

Refreshed Logo Conveys Change, Momentum (Pfizer Plus 4Q 2009 - registered users only)

Fall Signals Annual Benefits Enrollment and
Much More (Pfizer Plus 3Q 2009 - registered users only)

Pfizer Continues to Execute on Its Financial and Strategic Commitment (Pfizer Plus 3Q 2009 - registered users only)

Wyeth Acquisition Planning Update: Kindler Shares
His Thoughts (Pfizer Plus 3Q 2009 - registered users only)

Your Input Shapes Our Planning (Pfizer Plus 2Q 2009 - registered users only)

Creating The World's Premier Biopharmaceutical Company: Wyeth Acquisition Planning Update (Pfizer Plus 2Q 2009 - registered users only)

Pfizer Reports First-Quarter 2009 Results (Pfizer Plus 2Q 2009 - registered users only)

Spring Brings Changes to Plus In Print and Plus Online (Pfizer Plus 1Q 2009 - registered users only)

Pfizer Along the Path To the Future — Wyeth Acquisition (Pfizer Plus 1Q 2009 - registered users only)

Pfizer Reports 2008 Financial Objectives, Provides Guidance for 2009 (Pfizer Plus 1Q 2009 - registered users only)

In an Industry First, Pfizer Launches New Medicine Safety Web Site

For past Plus Pfizer articles in print, please visit the Plus newsletters archive section.